Company intelligence / Profile preview

Holland Biodiversity

Lisse, South Holland, Netherlands

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Results show successful supply of high-yield, reproducible bioactive plant materials and active substances (e.g., valeric acids), including bulk and laboratory-scale deliveries for research, product development, and manufacturing in pharma, cosmetics, nutrition, and natural crop protection.

Therapeutic areas: NeurologyInfectious DiseasesDermatology
Modalities: Plant extractPure compoundNatural product
Industry: Chemicals & Materials

Partnerships

Major partnerships not disclosed; collaborates broadly with companies in cosmetics, fragrances, natural crop protection, natural chemicals, nutrition, and pharmacy sectors

Beyond the preview

Go deeper on Holland Biodiversity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Holland Biodiversity.

Explore the full profile